Breast cancer

Mitochondrial ND3 G10398A mutation: a biomarker for breast cancer

Y. Yu, Lv, F., Lin, H., Qian, G., Jiang, Y. S., Pang, L. X., Wang, Y. P., Wang, X. F., Kang, Y. M., Li, C. B., Liu, Q., Xu, J. Z., and You, W., Mitochondrial ND3 G10398A mutation: a biomarker for breast cancer, vol. 14, pp. 17426-17431, 2015.

Mitochondrial DNA mutations have been found to play important roles in carcinogenesis. The most common G10398A mutation, a non-conservative amino acid substitution from Thr to Ala, seems to be involved in the tumorigenesis of breast cancer. Results from studies concerning this mutation remain inconclusive. In the current study, we first took clinical and molecular datasets from case-control studies to determine the association between the G10398A mutation and breast cancer. We further used the Phylotree to determine the haplogroups of this mutation.

AGER genetic polymorphisms increase risks of breast and lung cancers

N. C. Yin, Lang, X. P., Wang, X. D., and Liu, W., AGER genetic polymorphisms increase risks of breast and lung cancers, vol. 14, pp. 17776-17787, 2015.

We evaluated the associations between three common polymorphisms in the AGER gene and the risks of breast (BC) and lung (LC) cancer using meta-analysis. A systematic electronic search of the literature was conducted to identify all potential correlation studies in Embase, Web of Science, Cochrane Library, CINAHL, PubMed, CISCOM, China BioMedicine (CBM), and China National Knowledge Infrastructure (CNKI) databases.

Subscribe to Breast cancer